Mammograms are widely touted as an effective breast cancer screening tool. But some research and experts suggest that it could be causing more harm than good.
Here’s the truth – even if conventional oncology doesn’t want you to hear it – you can objectively determine your risk for cancer without the use of harmful radiation devices, like mammography.
The FDA published an article in "Journal Watch" on June 3, 2011 is full of information that is presumptive and incorrect and they have to know it.
Mammography has been the "gold standard" for detection of breast cancer, and with fears of breast cancer taking the forefront in many women’s minds today, the medical industry continues to push the use of mammography for prevention and early detection of this deadly disease. But we need to take a closer look at this concept.
Despite widely publicized claims to the contrary, thermography should not be used in place of mammography for breast cancer screening or diagnosis.
The Promise of Thermography: A guest article from the leading voice in women's holistic health by Christiane Northrup, M.D.
If you ask ten women, or men, if they are familiar with Breast Thermography, nine would say no.
William Cockburn, D.C., D.A.B.F.E., F.I.A.C.T
Breast cancer and other breast diseases have become a tremendous issue in women's health today, particularly in advanced industrialized nations. Also note that approximately 1,000 men get breast cancer yearly.
A procedure which has gone largely unnoticed is Breast Thermography, also known as Breast Thermal Imaging. Breast thermography promises the opportunity of earlier detection of breast disease than has been possible with breast self examination, physician palpation, or mammography.
Digital breast thermography, or Digital Infrared Thermal Imaging (DITI), is a noninvasive screening procedure that detects and records infrared heat emissions from the breast. The visual image, or thermogram, maps variations in skin temperature that may indicate underlying vascular, muscular and neural disease. DITI is especially useful for detecting early lesions before they otherwise become clinically evident. These changes could accompany cancer, fibrocystic breast disease, local injury, infections or vascular disease.